|
⚲
|
| Keyboard |
| AJU IB Investment Co Ltd
✚
|
|
|---|---|
| CIK # | 0001710065 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001710065] | |
| 3 | [0001710065] | |
| 4 | [0001710065] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| AJU IB Investment Co Ltd | |
| Apellis Pharmaceuticals Inc | |
| Rein Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2017-11-13 | Conversion | 2,292,062 | ||
|
Apellis Pharmaceuticals Inc APLS
Series C Preferred Stock · derivative
|
2017-11-13 | Conversion | 4,000,000 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Series D Preferred Stock · derivative
|
2017-11-13 | Conversion | 888,969 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Series E-3 Preferred Stock · derivative
|
2017-07-05 | Conversion | 4,411,765 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Common Stock
|
2017-07-05 | Buy | 24,929 | $15.00 | 373,935 |
|
Rein Therapeutics Inc ALRN
Series F Preferred Stock · derivative
|
2017-07-05 | Conversion | 483,501 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Common Stock
|
2017-07-05 | Conversion | 443,973 | ||
|
Rein Therapeutics Inc ALRN
Common Stock
|
2017-07-05 | Conversion | 48,656 |